Search for Clinical Trial Results
Leukemia-Lymphoma, Adult T-Cell - 25 Studies Found
Status | Study |
Active, not recruiting |
Study Name: Evaluation and Treatment of Tall Statured Girls Condition: Constitutional Tall Stature Date: 2015-12-13 Interventions: Drug: Estradiol Estradiol containing compounds administered orally in a non-randomized manner. |
Completed |
Study Name: A Phase I, Multicenter, Open-label, Dose-escalation Study to Assess the Safety of Lenalidomide in Patients With Advanced Adult T-cell Leukemia-lymphoma and Peripheral T-cell Lymphomaperipheral T-cell Lymphoma Condition:
Date: 2010-07-22 Interventions: Drug: Lenalidomide Lenalidomide: 25mg daily on day 1-21 of each 28days cycle (1st cohort), 25 mg daily o |
Completed |
Study Name: 506U78 In Relapsed Or Refractory Acute Lymphoblastic Leukemia (T-ALL) Condition: T-ALL, T-NHL (Lymphoblastic) Date: 2008-05-16 Interventions: Drug: Nelarabine 1500 mg/m² i.v., duration 2 hrs, day 1, 3, 5 |
Completed |
Study Name: EPOCH Chemotherapy and Bortezomib for Associated T-Cell Leukemia Lymphoma Condition: Leukemia-Lymphoma, Adult T-Cell Date: 2009-10-19 Interventions:
|
Recruiting |
Study Name: Subcutaneous Recombinant Human IL-15 (s.c. rhIL-15) and Alemtuzumab for People With Refractory or Relapsed Chronic and Acute Adult T-cell Leukemia (ATL) Condition:
|
Completed |
Study Name: Multicenter, Randomized, Open-label, Parallel-group Study to Compare mLSG15 + KW-0761 to mLSG15 Condition: Adult T-cell Leukemia-Lymphoma Date: 2010-07-30 Interventions:
|
Completed |
Study Name: Pilot Study of Combination Therapy With CHOP-Zenapax (CHOP-daclizumab) Condition: HTLV-I Associated Adult T-cell Leukaemia/Lymphoma (ATLL) Date: 2011-08-16 Interventions: Drug: CHOP-daclizumab Other Name: CHOP-Zenapax |
Completed |
Study Name: Trial to Assess Effect of Raltegravir on HTLV-1 Proviral Load Condition: Human T-cell Leukemia Virus Type 1 Infection Date: 2012-01-25 Interventions: Drug: Raltegravir Raltegravir 400 mg po bid |
Completed |
Study Name: Phase I Study of KW-0761 in Relapsed Patients With CCR4-Positive ATL and PTCL Condition:
|
Recruiting |
Study Name: Ruxolitinib for Adult T-Cell Leukemia Condition:
|